Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
38
UTI Quote, Financials, Valuation and Earnings
Last price:
$32.54
Seasonality move
:
-6.32%
Day range:
$31.56 - $32.35
52-week range:
$15.14 - $36.32
Dividend yield:
0%
P/E ratio:
30.63x
P/S ratio:
2.26x
P/B ratio:
5.90x
Volume:
447.1K
Avg. volume:
649K
1-year change:
76.51%
Market cap:
$1.7B
Revenue:
$732.7M
EPS (TTM):
$1.04
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $300.8M | $335.1M | $418.8M | $607.4M | $732.7M | |
| Revenue Growth (YoY) | -9.27% | 11.41% | 24.97% | 45.05% | 20.63% | |
| Cost of Revenues | $155.9M | $166.8M | $207.2M | $329.9M | $384.5M | |
| Gross Profit | $144.8M | $168.3M | $211.5M | $277.5M | $348.2M | |
| Gross Profit Margin | 48.15% | 50.22% | 50.51% | 45.69% | 47.52% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $148.7M | $153.3M | $189.2M | $256.1M | $289.3M | |
| Other Inc / (Exp) | $135K | $518K | -$438K | $483K | $496K | |
| Operating Expenses | $148.7M | $153.3M | $189.2M | $256.1M | $289.3M | |
| Operating Income | -$3.9M | $14.9M | $22.4M | $21.4M | $58.9M | |
| Net Interest Expenses | -- | $282K | $1.5M | $3.8M | $3.2M | |
| EBT. Incl. Unusual Items | -$2.6M | $15.2M | $20.4M | $18.1M | $56.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$10.6M | $602K | -$5.4M | $5.8M | $14.2M | |
| Net Income to Company | $8M | $14.6M | $25.8M | $12.3M | $42M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $8M | $14.6M | $25.8M | $12.3M | $42M | |
| Basic EPS (Cont. Ops) | $0.05 | $0.17 | $0.39 | $0.13 | $0.77 | |
| Diluted EPS (Cont. Ops) | $0.05 | $0.17 | $0.38 | $0.13 | $0.75 | |
| Weighted Average Basic Share | $29.8M | $32.8M | $33.2M | $34M | $49.4M | |
| Weighted Average Diluted Share | $30.1M | $33.1M | $33.7M | $34.5M | $50.9M | |
| EBITDA | $33.5M | $45.2M | $55.2M | $73.6M | $116.9M | |
| EBIT | -$2.6M | $15.5M | $22.4M | $27.7M | $65.7M | |
| Revenue (Reported) | $300.8M | $335.1M | $418.8M | $607.4M | $732.7M | |
| Operating Income (Reported) | -$3.9M | $14.9M | $22.4M | $21.4M | $58.9M | |
| Operating Income (Adjusted) | -$2.6M | $15.5M | $22.4M | $27.7M | $65.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $77.7M | $102.1M | $163.8M | $184.2M | $207.4M | |
| Revenue Growth (YoY) | -6.05% | 31.37% | 60.47% | 12.43% | 12.64% | |
| Cost of Revenues | $40.5M | $49.2M | $86.9M | $97.5M | $102.5M | |
| Gross Profit | $37.2M | $52.9M | $76.9M | $86.7M | $105M | |
| Gross Profit Margin | 47.91% | 51.8% | 46.94% | 47.07% | 50.6% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $38.7M | $49.5M | $70.9M | $75.5M | $88.1M | |
| Other Inc / (Exp) | $73K | -$163K | $126K | $119K | $9K | |
| Operating Expenses | $38.9M | $49.5M | $70.9M | $75.5M | $88.1M | |
| Operating Income | -$1.7M | $3.4M | $5.9M | $11.2M | $16.9M | |
| Net Interest Expenses | -- | $458K | $832K | $757K | $28K | |
| EBT. Incl. Unusual Items | -$1.6M | $2.8M | $5.2M | $10.6M | $16.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$34K | -$4.6M | $1.8M | $2.8M | $5.4M | |
| Net Income to Company | -$1.5M | $7.4M | $3.5M | $7.8M | $11.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$1.5M | $7.4M | $3.5M | $7.8M | $11.4M | |
| Basic EPS (Cont. Ops) | -$0.09 | $0.11 | $0.04 | $0.14 | $0.21 | |
| Diluted EPS (Cont. Ops) | -$0.09 | $0.11 | $0.04 | $0.14 | $0.21 | |
| Weighted Average Basic Share | $32.8M | $33M | $34M | $53.8M | $54.4M | |
| Weighted Average Diluted Share | $32.8M | $33.4M | $34.6M | $54.8M | $55.4M | |
| EBITDA | $5.7M | $11.8M | $20.6M | $25.4M | $32.4M | |
| EBIT | -$1.6M | $3.2M | $7.9M | $12.7M | $18.5M | |
| Revenue (Reported) | $77.7M | $102.1M | $163.8M | $184.2M | $207.4M | |
| Operating Income (Reported) | -$1.7M | $3.4M | $5.9M | $11.2M | $16.9M | |
| Operating Income (Adjusted) | -$1.6M | $3.2M | $7.9M | $12.7M | $18.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $284.6M | $388.4M | $495.4M | $682.5M | $782.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $150M | $184.1M | $258.5M | $371.4M | $397.3M | |
| Gross Profit | $134.7M | $204.3M | $237M | $311M | $385.4M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $143.4M | $171.9M | $221.2M | $274.6M | $307.6M | |
| Other Inc / (Exp) | $819K | $118K | $58K | $365K | $137K | |
| Operating Expenses | $143.2M | $171.5M | $221.2M | $274.6M | $307.6M | |
| Operating Income | -$8.5M | $32.8M | $15.8M | $36.4M | $77.8M | |
| Net Interest Expenses | -- | $1M | $2.2M | $4M | $1.4M | |
| EBT. Incl. Unusual Items | -$7.2M | $31.9M | $13.6M | $32.8M | $76.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $110K | -$5.3M | $3.8M | $8.4M | $19.1M | |
| Net Income to Company | -$7.3M | $37.2M | $9.8M | $24.4M | $57.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$7.3M | $37.2M | $9.8M | $24.4M | $57.4M | |
| Basic EPS (Cont. Ops) | -$0.45 | $0.59 | $0.09 | $0.37 | $1.06 | |
| Diluted EPS (Cont. Ops) | -$0.46 | $0.59 | $0.08 | $0.36 | $1.04 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $26.1M | $64.3M | $57.1M | $92.3M | $137.7M | |
| EBIT | -$7.2M | $32.9M | $19M | $43.4M | $84.2M | |
| Revenue (Reported) | $284.6M | $388.4M | $495.4M | $682.5M | $782.7M | |
| Operating Income (Reported) | -$8.5M | $32.8M | $15.8M | $36.4M | $77.8M | |
| Operating Income (Adjusted) | -$7.2M | $32.9M | $19M | $43.4M | $84.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $153.8M | $207.2M | $283.8M | $358.9M | $408.9M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $79.8M | $97.1M | $148.3M | $189.9M | $202.6M | |
| Gross Profit | $74M | $110.1M | $135.5M | $169M | $206.2M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $74.5M | $93.1M | $125.1M | $143.6M | $161.9M | |
| Other Inc / (Exp) | $355K | -$45K | $451K | $333K | -$26K | |
| Operating Expenses | $74.9M | $93.1M | $125.1M | $143.6M | $161.9M | |
| Operating Income | -$886K | $17M | $10.4M | $25.4M | $44.3M | |
| Net Interest Expenses | -- | $679K | $1.4M | $1.7M | $28K | |
| EBT. Incl. Unusual Items | -$472K | $16.2M | $9.4M | $24.1M | $44.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$8K | -$5.9M | $3.3M | $5.9M | $10.8M | |
| Net Income to Company | -$464K | $22.2M | $6.1M | $18.2M | $33.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$464K | $22.2M | $6.1M | $18.2M | $33.6M | |
| Basic EPS (Cont. Ops) | -$0.10 | $0.36 | $0.07 | $0.32 | $0.62 | |
| Diluted EPS (Cont. Ops) | -$0.10 | $0.36 | $0.06 | $0.31 | $0.61 | |
| Weighted Average Basic Share | $65.4M | $65.8M | $67.8M | $90.2M | $108.4M | |
| Weighted Average Diluted Share | $65.4M | $67M | $69M | $92.2M | $110.8M | |
| EBITDA | $14.5M | $33.6M | $35.5M | $54.3M | $75.1M | |
| EBIT | -$469K | $16.9M | $13.5M | $29.2M | $47.7M | |
| Revenue (Reported) | $153.8M | $207.2M | $283.8M | $358.9M | $408.9M | |
| Operating Income (Reported) | -$886K | $17M | $10.4M | $25.4M | $44.3M | |
| Operating Income (Adjusted) | -$469K | $16.9M | $13.5M | $29.2M | $47.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $76.8M | $133.7M | $66.5M | $151.5M | $161.9M | |
| Short Term Investments | $38.1M | -- | $28.9M | -- | -- | |
| Accounts Receivable, Net | $23.6M | $16.3M | $18.9M | $29.6M | $35.3M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $6.1M | $6.7M | $6.1M | $9.4M | $11.9M | |
| Other Current Assets | $6.5M | $8.1M | $8.8M | $7.5M | $5.2M | |
| Total Current Assets | $180.2M | $183.4M | $136M | $205M | $222M | |
| Property Plant And Equipment | $217.4M | $281.1M | $346.3M | $443M | $423.6M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $8.2M | $8.2M | $16.9M | $28.5M | $28.5M | |
| Other Intangibles | -- | $124K | $14.2M | $19M | $18.2M | |
| Other Long-Term Assets | $8.6M | $9.1M | $6M | $10.8M | $12.5M | |
| Total Assets | $442M | $512.6M | $552.9M | $740.7M | $744.6M | |
| Accounts Payable | $12.5M | $13.7M | $21.7M | $14.4M | $26.3M | |
| Accrued Expenses | $14.5M | $14.5M | $16.5M | $19.2M | $21.9M | |
| Current Portion Of Long-Term Debt | $129K | $876K | $1.1M | $2.5M | $2.7M | |
| Current Portion Of Capital Lease Obligations | $23.7M | $14.1M | $13M | $22.5M | $22.2M | |
| Other Current Liabilities | $2.1M | $2.4M | $2.7M | $4M | $3.7M | |
| Total Current Liabilities | $121.6M | $132.7M | $137.7M | $184.7M | $205M | |
| Long-Term Debt | $131K | $29.9M | $66.4M | $159.6M | $123M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $265.5M | $324M | $337.5M | $514.7M | $484.3M | |
| Common Stock | $3K | $3K | $3K | $3K | $5K | |
| Other Common Equity Adj | -- | -$279K | $2.2M | $2.5M | $1.1M | |
| Common Equity | $176.5M | $188.5M | $215.4M | $226M | $260.2M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $176.5M | $188.5M | $215.4M | $226M | $260.2M | |
| Total Liabilities and Equity | $442M | $512.6M | $552.9M | $740.7M | $744.6M | |
| Cash and Short Terms | $114.9M | $133.7M | $95.4M | $151.5M | $161.9M | |
| Total Debt | $260K | $30.7M | $67.5M | $162.1M | $125.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $59M | $61.5M | $120.6M | $116.1M | $96M | |
| Short Term Investments | $19.5M | -- | -- | -- | $39.7M | |
| Accounts Receivable, Net | $19.8M | $15.5M | $25.4M | $24.3M | $31.2M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $8.3M | $8M | $9.9M | $12.2M | $14.1M | |
| Other Current Assets | $6.4M | $7.5M | $8.7M | $7M | $6.6M | |
| Total Current Assets | $131.1M | $109.5M | $174.6M | $170.2M | $198.5M | |
| Property Plant And Equipment | $262.6M | $334.8M | $445.5M | $433.2M | $415.8M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $8.2M | $16.9M | $28.5M | $28.5M | $28.5M | |
| Other Intangibles | -- | $16.3M | $19.3M | $18.6M | $17.8M | |
| Other Long-Term Assets | $9.5M | $5.3M | $9M | $12.1M | $15.9M | |
| Total Assets | $440.3M | $517.4M | $712.7M | $702.1M | $720.4M | |
| Accounts Payable | $10.6M | $9.1M | $11.8M | $17.7M | $19.8M | |
| Accrued Expenses | $15.2M | $20.2M | $21.5M | $23.5M | $25.8M | |
| Current Portion Of Long-Term Debt | -- | $2.4M | $2.3M | $2.6M | $2.8M | |
| Current Portion Of Capital Lease Obligations | $19.6M | $12.9M | $21.2M | $22.8M | $21.9M | |
| Other Current Liabilities | $1.9M | $2.3M | $3.7M | $3.3M | $5.7M | |
| Total Current Liabilities | $114.8M | $118.4M | $154.5M | $166.4M | $185.1M | |
| Long-Term Debt | -- | $46M | $160.8M | $139.3M | $91.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $263.9M | $306.6M | $491.8M | $469.5M | $426.5M | |
| Common Stock | $3K | $3K | $3K | $5K | $5K | |
| Other Common Equity Adj | -- | $755K | $1.5M | $1.9M | $1.3M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -$183K | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $176.5M | $210.7M | $220.9M | $232.6M | $293.9M | |
| Total Liabilities and Equity | $440.3M | $517.4M | $712.7M | $702.1M | $720.4M | |
| Cash and Short Terms | $78.5M | $61.5M | $120.6M | $116.1M | $135.7M | |
| Total Debt | -- | $48.4M | $163.1M | $141.9M | $94.4M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $8M | $14.6M | $25.8M | $12.3M | $42M | |
| Depreciation & Amoritzation | $36.1M | $29.6M | $32.8M | $45.8M | $51.2M | |
| Stock-Based Compensation | $2.1M | $1.7M | $4.3M | $3.8M | $8.6M | |
| Change in Accounts Receivable | -$18.5M | $13.9M | $816K | -$5M | -$17.9M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $11M | $55.2M | $46M | $49.1M | $85.9M | |
| Capital Expenditures | $9.3M | $61.3M | $79.5M | $56.7M | $24.3M | |
| Cash Acquisitions | $261K | $277K | -$26.3M | -$16.4M | -- | |
| Cash From Investing | -$45.8M | -$23M | -$134.6M | -$44.1M | -$24M | |
| Dividends Paid (Ex Special Dividend) | -$5.3M | -$5.3M | -$5.2M | -$5.1M | -$1.1M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $31.2M | $38M | $90M | $41M | |
| Long-Term Debt Repaid | -$99K | -$383K | -$19.2M | -$1.8M | -$77.5M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$11.5M | |
| Other Financing Activities | -$698K | -$693K | -$1M | -$1.3M | -$2.2M | |
| Cash From Financing | $43.1M | $24.8M | $12.6M | $81.8M | -$51.3M | |
| Beginning Cash (CF) | $80.6M | $88.9M | $133.7M | $66.5M | $151.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $8.4M | $57.1M | -$67.3M | $85.1M | $10.4M | |
| Ending Cash (CF) | $88.9M | $146M | $66.5M | $151.5M | $161.9M | |
| Levered Free Cash Flow | $1.8M | -$6.1M | -$33.4M | -$7.5M | $61.6M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $3M | $843K | -$509K | $5M | -- | |
| Depreciation & Amoritzation | $7.4M | $8.1M | $12M | $12.9M | -- | |
| Stock-Based Compensation | -$596K | $1M | $533K | $1.9M | -- | |
| Change in Accounts Receivable | -$7.4M | -$10.9M | $1.6M | -$8.4M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$2.7M | -$2.5M | -$418K | $10M | -- | |
| Capital Expenditures | $4.3M | $16.5M | $10.2M | $7M | -- | |
| Cash Acquisitions | $76K | -- | $592K | -- | -- | |
| Cash From Investing | $15M | -$16.5M | -$9.6M | -$6.7M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $31.2M | $38M | -- | $16M | -- | |
| Long-Term Debt Repaid | -$98K | -$18.3M | -$464K | -$20.6M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$272K | -$360K | -$13K | -$72K | -- | |
| Cash From Financing | $30.8M | $19.3M | -$477K | -$4.7M | -- | |
| Beginning Cash (CF) | $71.8M | $73M | $124.6M | $120.5M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $43M | $361K | -$10.5M | -$1.4M | -- | |
| Ending Cash (CF) | $114.8M | $73.3M | $114.1M | $119.1M | -- | |
| Levered Free Cash Flow | -$7.1M | -$19M | -$10.6M | $3M | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$7.3M | $37.2M | $9.8M | $24.4M | $57.4M | |
| Depreciation & Amoritzation | $33.3M | $31.4M | $38.2M | $48.9M | $53.5M | |
| Stock-Based Compensation | $2.9M | $2.2M | $5.4M | $4.4M | $8.5M | |
| Change in Accounts Receivable | $3.8M | $2.5M | -$7.3M | -$6.6M | -$27M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $17.7M | $48.1M | $31.3M | $61.8M | $99.7M | |
| Capital Expenditures | $54M | $64.5M | $64.9M | $27.8M | $28.8M | |
| Cash Acquisitions | $269K | -$26.2M | -$17M | $592K | -- | |
| Cash From Investing | -$30.8M | -$70.9M | -$81.7M | -$27.2M | -$68.2M | |
| Dividends Paid (Ex Special Dividend) | -$5.3M | -$5.2M | -$5.1M | -$3.6M | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $31.2M | $128M | $20M | -- | |
| Long-Term Debt Repaid | -$126K | -$997K | -$19.3M | -$41.3M | -$68.6M | |
| Repurchase of Common Stock | -- | -- | -- | -$11.5M | -- | |
| Other Financing Activities | -$572K | -$920K | -$1.6M | -$2.2M | -$4.6M | |
| Cash From Financing | -$5.9M | $24M | $102M | -$38.6M | -$51.5M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$19.1M | $1.2M | $60.3M | -$5.9M | -$20.2M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$36.4M | -$16.5M | -$33.6M | $34M | $70.9M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.5M | $23M | $5.6M | $23.2M | $33.6M | |
| Depreciation & Amoritzation | $22.3M | $24.8M | $34.1M | $38M | $27.5M | |
| Stock-Based Compensation | $1.2M | $3.3M | $3.8M | $5.7M | $3.7M | |
| Change in Accounts Receivable | $7.7M | -$7.3M | -$2.9M | -$14.4M | -$15.1M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $14.8M | $7.9M | -$4.7M | $18.4M | $22.2M | |
| Capital Expenditures | $54.2M | $69.6M | $48.8M | $16.8M | $14.3M | |
| Cash Acquisitions | $226K | -$26.3M | -$16.4M | -- | -- | |
| Cash From Investing | -$16.6M | -$95.9M | -$36.2M | -$16.5M | -$54M | |
| Dividends Paid (Ex Special Dividend) | -$2.6M | -$2.6M | -$2.5M | -$1.1M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $31.2M | $38M | $90M | $36M | -- | |
| Long-Term Debt Repaid | -$162K | -$19M | -$1.2M | -$60.9M | -$31.3M | |
| Repurchase of Common Stock | -- | -- | -- | -$11.5M | -- | |
| Other Financing Activities | -$673K | -$988K | -$1.2M | -$2.2M | -$4.5M | |
| Cash From Financing | $27.7M | $15.4M | $85M | -$39.7M | -$35.1M | |
| Beginning Cash (CF) | $192.8M | $306.2M | $361.4M | $426.3M | $345.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $25.9M | -$72.6M | $44.1M | -$37.8M | -$67M | |
| Ending Cash (CF) | $230.8M | $245.8M | $405.4M | $388.5M | $278.3M | |
| Levered Free Cash Flow | -$39.5M | -$61.7M | -$53.6M | $1.6M | $7.9M | |
Get UTI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
UTI
Sector
P/E ratio
30.63x
16.92x
PEG ratio
0.16x
0.17x
P/B ratio
5.90x
1.42x
Price / LTM sales
2.26x
0.68x
Growth Metrics
UTI
Sector
Revenue growth
12.64%
0.64%
Earnings growth
50%
-1.02%
Revenue (5-year growth)
17.19%
3.61%
Earnings forecast
$0.18
$0.24
Profitability
UTI
Sector
Profitability FY 2024
$348.2M
$456.7M
Return on invested capital
14.91%
4.58%
Return on assets
7.92%
2.72%
Return on equity
21.98%
6.7%
Earnings Date
Last Earnings Date
May
7
Next Earnings Date
Aug
6
Estimated Next Earnings Date
Aug
6
Balance Sheet
UTI
Sector
Total cash
$135.7M
$139.6M
Short term investments
--
$46.8M
Total assets
$744.6M
$1.4B
Long term debt
$94.4M
$128.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
